In an interview with CNBC-TV18, Pravin Shivdas Harlekar, MD, Omkar Speciality says, the company is targeting atleast 45% revenue growth in FY12.
Here is a verbatim transcript of the exclusive interview with Pravin Shivdas Harlekar on CNBC-TV18. Also watch the accompanying video. Q: Your stock price has surged in the last couple of trading sessions, is there anything that the shareholders are missing? Also, you had a board meeting today, what was the outcome of that? A: The board meeting was a routine meeting to take a stock of the situation and then to review the operations for last year i.e.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!